Blood component use and associated costs after standard dose chemotherapy—a prospective analysis of routine hospital care in lymphoproliferative disorders and NSCLC in Germany

B. Paessens,Angela Ihbe-Heffinger,Christoph von Schilling,Rita Shlaen,Rudolf Bernard,Christian Peschel,W. Schramm,K. Berger

Blood component use and associated costs after standard dose chemotherapy—a prospective analysis of routine hospital care in lymphoproliferative disorders and NSCLC in Germany

2012

B. Paessens
Angela Ihbe-Heffinger
Christoph von Schilling
Rita Shlaen
Rudolf Bernard
Christian Peschel
W. Schramm
K. Berger

Purpose The purpose of this study was to describe blood component (BC) use and respective cost after standard dose chemotherapy (CT) in routine hospital care.

Keywords:

Platelet transfusion
Intensive care medicine
Lymphoproliferative disorders
Blood Component Transfusion
Chemotherapy
Medicine
standard dose chemotherapy
blood component
hospital care
prospective analysis
erythrocyte transfusion

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations